InvestorsHub Logo
Followers 831
Posts 120032
Boards Moderated 17
Alias Born 09/05/2002

Re: DaveAu post# 1844

Sunday, 02/09/2020 12:07:28 PM

Sunday, February 09, 2020 12:07:28 PM

Post# of 3017
Thanks for posting that excerpt. EDP-297 sounds highly promising.

Inasmuch as finding an effective and well-tolerated dose of EDP-305 looks like a longshot, I think ENTA should redirect the R&D expenditures on EDP-305 to EDP-297, instead of advancing both compounds.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ENTA News